Immature Neuron Marker
The results obtained in the cerebral cortex would suggest a rather sharp definition of “immature” neurons as non-newly generated, prenatally generated cells.
With the rapid development of tumor immunotherapy, precise assessment of the tumor microenvironment (TME) has become a core prerequisite for interpreting immune escape mechanisms, screening populations benefiting from immunotherapy, and optimizing treatment regimens. Traditional single-marker immunohistochemistry (IHC) and immunofluorescence (IF) techniques can only detect a single marker, failing to comprehensively present the complex composition of immune cell subsets, marker co-expression characteristics, and intercellular spatial relationships in the TME, which is insufficient to meet the needs of precise immunotherapy research and clinical applications. Against this backdrop, multiplex immunohistochemistry (mIHC) and multiplex immunofluorescence (mIF) technologies have emerged and rapidly iterated, becoming core technologies for parsing TME heterogeneity and mining immunotherapy biomarkers due to their advantage of simultaneously detecting multiple markers in tissue sections.